Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy
- DOI
- 10.1177/20406207261484097
- Published
- 2026-08
- Container
- Therapeutic Advances in Hematology
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/20406207261484097,
title = {Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy},
author = {Abdulrahman F. Al-Mashdali and Mujahid O. Abdelraof and Monia Ibrahim and Mohammed Abdulgayoom and Shehab F. Mohamed and Honar Cherif},
year = {2026},
journal = {Therapeutic Advances in Hematology},
doi = {10.1177/20406207261484097},
url = {https://doi.org/10.1177/20406207261484097}
}RIS
TY - JOUR TI - Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy AU - Abdulrahman F. Al-Mashdali AU - Mujahid O. Abdelraof AU - Monia Ibrahim AU - Mohammed Abdulgayoom AU - Shehab F. Mohamed AU - Honar Cherif PY - 2026 JO - Therapeutic Advances in Hematology DO - 10.1177/20406207261484097 UR - https://doi.org/10.1177/20406207261484097 ER -
APA
Al-Mashdali, A. F., Abdelraof, M. O., Ibrahim, M., Abdulgayoom, M., Mohamed, S. F., & Cherif, H. (2026). Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy. Therapeutic Advances in Hematology. https://doi.org/10.1177/20406207261484097
Source records
- crossref · retrieved 2026-09-27T07:02:10.968Z